<DOC>
	<DOCNO>NCT00101725</DOCNO>
	<brief_summary>This study design evaluate safety effectiveness investigational drug , TRN-002 ( crofelemer ) relieve symptoms diarrhea-predominant irritable bowel syndrome ( IBS ) .</brief_summary>
	<brief_title>A Study Crofelemer Treat Diarrhea Irritable Bowel Syndrome</brief_title>
	<detailed_description>The investigational drug natural product take plant grow South America . The study medication administer orally twice day . Subjects eligible participate 75 % chance receive TRN-002 25 % chance receive placebo ( substance look similar TRN 002 activity ) . Subjects able remain certain standard IBS medication ( antidiarrheal ) participate study . The total duration 16 week . The study require five study visit include physical exam , ECG blood draw laboratory study . A colon procedure ( colonoscopy flexible sigmoidoscopy ) may also require perform since diagnosis within last 5 year . Participants ask make daily entry touch-tone telephone diary daily basis .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Colonic Diseases</mesh_term>
	<criteria>Diagnosis diarrhea predominant Irritable Bowel Syndrome Willingness make daily call touchtone telephone Willingness endoscopic and/or radiologic bowel evaluation , receive one since IBS diagnosis past 5 year Willingness use approve method birth control Serious medical surgical condition Gastrointestinal Cancers , Crohns Disease Ulcerative Colitis Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Diarrhea</keyword>
	<keyword>IBS</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Abdominal pain</keyword>
</DOC>